BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6615399)

  • 1. The effects of oral nafazatrom (= BAY g 6575) on canine coronary artery thrombosis and myocardial ischemia.
    Fiedler VB
    Basic Res Cardiol; 1983; 78(3):266-80. PubMed ID: 6615399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of nafazatrom in an acute occlusion-reperfusion model of canine myocardial injury.
    Fiedler VB; Mardin M; Perzborn E; Grützmann R
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):267-74. PubMed ID: 3841382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of acute myocardial ischemia in rabbit hearts by nafazatrom.
    Fiedler VB
    J Cardiovasc Pharmacol; 1984; 6(2):318-24. PubMed ID: 6200722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolytic effects of intracoronary streptokinase on canine coronary artery thrombosis.
    Fiedler VB
    Basic Res Cardiol; 1984; 79(1):17-26. PubMed ID: 6732717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis.
    Shea MJ; Driscoll EM; Romson JL; Pitt B; Lucchesi BR
    Am Heart J; 1984 Apr; 107(4):629-37. PubMed ID: 6702555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of occlusive coronary artery thrombosis and myocardial ischemia by molsidomine in anesthetized dogs.
    Fiedler VB
    Can J Physiol Pharmacol; 1982 Aug; 60(8):1104-11. PubMed ID: 6897011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of canine coronary collateral flow by nafazatrom.
    Fiedler VB; Mardin M
    Eur J Pharmacol; 1986 Nov; 130(3):157-67. PubMed ID: 3792445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nafazatrom and indomethacin on experimental myocardial ischemia in the anesthetized dog.
    Fiedler VB; Mardin M
    J Cardiovasc Pharmacol; 1985; 7(5):983-9. PubMed ID: 2413312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of nafazatrom on ischemic reperfused myocardium.
    Shea MJ; Murtagh JJ; Jolly SR; Abrams GD; Pitt B; Lucchesi BR
    Eur J Pharmacol; 1984 Jun; 102(1):63-70. PubMed ID: 6479219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function.
    Bednar M; Smith B; Pinto A; Mullane KM
    Circ Res; 1985 Jul; 57(1):131-41. PubMed ID: 2988818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of nafazatrom to reduce infarct size and arrhythmias in a porcine model of acute coronary occlusion.
    Fiedler VB
    Eur J Pharmacol; 1985 Aug; 114(2):189-95. PubMed ID: 3930268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of zomepirac on experimental coronary artery thrombosis and ischemic myocardial injury in the conscious dog.
    Hook BG; Romson JL; Jolly SR; Bailie MB; Lucchesi BR
    J Cardiovasc Pharmacol; 1983; 5(2):302-8. PubMed ID: 6188907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of myocardial infarction and dysrhythmic activity by nafazatrom in the conscious rat.
    Fiedler VB
    Eur J Pharmacol; 1983 Mar; 88(2-3):263-7. PubMed ID: 6852112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death.
    Fiedler VB; Mardin M
    Basic Res Cardiol; 1986; 81(1):40-53. PubMed ID: 3521579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of nafazatrom on arrhythmias and prostanoid release during coronary artery occlusion and reperfusion in anaesthetized greyhounds.
    Coker SJ; Parratt JR
    J Mol Cell Cardiol; 1984 Jan; 16(1):43-52. PubMed ID: 6366241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of prostacyclin on coronary thrombosis and myocardial ischemia in conscious canine experiments.
    Fiedler VB; Mardin M
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):114-27. PubMed ID: 3913392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of carbocromene on ventricular fibrillation during acute myocardial ischemia in anesthetized dogs.
    Fiedler VB; Schneider S; Nitz RE
    Pharmacology; 1982; 25(2):96-101. PubMed ID: 7134263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoxygenase inhibitor nafazatrom fails to attenuate postischaemic ventricular dysfunction.
    O'Neill PG; Charlat ML; Kim HS; Pocius J; Michael LH; Hartley CJ; Zhu WX; Roberts R; Bolli R
    Cardiovasc Res; 1987 Oct; 21(10):755-60. PubMed ID: 3125975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ortho-iodo sodium benzoate on acute myocardial ischemia, hemodynamic function, and infarct size after coronary artery occlusion in dogs.
    Rude RE; Tumas J; Gunst M; Kloner RA; DeBoer LW; Maroko PR
    Am J Cardiol; 1983 May; 51(8):1422-7. PubMed ID: 6846170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of efficacy of nafazatrom, a novel anti-thrombotic compound, in patients with coronary artery disease.
    Roy L; Mehta J; Mehta P
    Am Heart J; 1985 May; 109(5 Pt 1):1026-31. PubMed ID: 3158183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.